Ozsoy F, Tasci G, Tasci B, Dogan S, Tuncer T. Artificial intelligence for the diagnosis and treatment response prediction of obsessive-compulsive disorder: A narrative review. World J Psychiatry 2026; 16(7): 118161 [DOI: 10.5498/wjp.118161]
Corresponding Author of This Article
Burak Tasci, PhD, Vocational School of Technical Sciences, Firat University, Cahit Arf Street, Elazig 23119, Türkiye. btasci@firat.edu.tr
Research Domain of This Article
Computer Science, Artificial Intelligence
Article-Type of This Article
review-article
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Ozsoy F, Tasci G, Tasci B, Dogan S, Tuncer T. Artificial intelligence for the diagnosis and treatment response prediction of obsessive-compulsive disorder: A narrative review. World J Psychiatry 2026; 16(7): 118161 [DOI: 10.5498/wjp.118161]
Filiz Ozsoy, Department of Psychiatry, Tokat Gaziosmanpasa University, Tokat 60100, Türkiye
Gulay Tasci, Department of Psychiatry, Elazig Fethi Sekin City Hospital, Elazig 23100, Türkiye
Burak Tasci, Vocational School of Technical Sciences, Firat University, Elazig 23119, Türkiye
Sengul Dogan, Turker Tuncer, Department of Digital Forensics Engineering, College of Technology, Firat University, Elazig 23119, Türkiye
Co-corresponding authors: Gulay Tasci and Burak Tasci.
Author contributions: Ozsoy F contributed to conceptualization, clinical content supervision, validation, writing review and editing; Tasci G and Tasci B contributed to clinical literature review, data interpretation, writing review, conceptualization, methodology, artificial intelligence-related content development, writing, original draft, supervision as co-corresponding authors; Dogan S contributed to artificial intelligence methodology analysis, data curation, writing, technical sections; Tuncer T contributed to computational modeling review, technical validation, writing, review and editing; all of the authors read and approved the final version of the manuscript to be published.
Conflict-of-interest statement: All authors declare no conflict of interest in publishing the manuscript.
Corresponding author: Burak Tasci, PhD, Vocational School of Technical Sciences, Firat University, Cahit Arf Street, Elazig 23119, Türkiye. btasci@firat.edu.tr
Received: December 25, 2025 Revised: January 25, 2026 Accepted: March 2, 2026 Published online: July 19, 2026 Processing time: 183 Days and 5 Hours
Abstract
Obsessive-compulsive disorder (OCD) exists as a persistent psychiatric condition which produces different symptoms that lead to severe personal distress and complete social and work disability and major expenses for communities. The field of neurobiology has made progress but doctors still face two main clinical obstacles which include delayed diagnoses and inconsistent treatment outcomes and numerous cases of medication failure. The field of psychiatry now benefits from two separate developments which include artificial intelligence (AI) advancements and psychiatric treatment method improvements. This study is a narrative review that synthesizes existing evidence on the application of AI in OCD, with a focus on diagnostic models, treatment response prediction, and clinical decision support systems. The research combines existing data about AI usage in OCD treatment through its evaluation of diagnostic methods and treatment prediction models and clinical decision systems. The research team performed a thorough evaluation of studies which used machine learning and deep learning models to analyze neuroimaging data and electrophysiological signals and clinical scales and digital phenotyping information and multiple data sources. The research evaluated two new roles of large language models together with explainable AI methods which assess their potential for medical interpretation and their ethical implications and their ability to translate into practice. The research findings show that AI-based models demonstrate successful results in identifying OCD patients from healthy participants and in forecasting treatment outcomes for pharmacological and psychotherapeutic and neuromodulation interventions. Research shows that models which use multiple data sources produce better results than systems which depend on a single data source because OCD exists as a complex combination of neurological and behavioral elements. The reported study results show significant differences between research investigations because the studies used different data sources and testing methods and validation approaches. The current limitations in explainability together with insufficient external validation and small available data samples prevent these models from being used in clinical practice. AI provides substantial potential to enhance precision psychiatric care for OCD patients through its ability to detect conditions earlier and create personalized treatment plans and provide continuous clinical guidance. The process of translating this technology into medical practice needs research studies which must be conducted in multiple centers throughout different time periods while using AI systems that provide explanations and follow human-friendly design principles. The deployment of AI tools for obsessive-compulsive disorder management requires solutions to address ethical issues and regulatory requirements and interpretability problems for safe and dependable and enduring implementation.
Core Tip: This review highlights that artificial intelligence (AI) enables earlier and more accurate obsessive-compulsive disorder identification by integrating multimodal biomarkers (magnetic resonance imaging, electroencephalography, clinical scales, and digital phenotyping), surpassing unimodal models. Its key innovation is the joint clinical role of explainable AI for transparent neurobiological interpretation and large language models for personalized, scalable clinical decision support. Limited explainability, small samples, and weak external validation remain the main barriers to clinical translation. Future obsessive-compulsive disorder care requires multicenter, longitudinal, and clinician-aligned explainable AI systems to ensure ethical, regulatory, and trustworthy implementation.